Company Overview

Update
Headquarters:
London
Funding:
$20M
Categories:
Biotechnology
Description:
Viron Therapeutics, a clinical-stage biopharmaceutical company, develops viral proteins to treat and prevent human inflammatory disorders.

Detailed Description

Update

Viron Therapeutics is a clinical stage biopharmaceutical company pioneering the development of viral proteins to treat and prevent human inflammatory disorders. Viral proteins represent a revolutionary new class of drugs. By harnessing the evolutionary power of viruses and other pathogens to evade the human body's protective inflammatory response, Viron is able to identify and develop powerful protein therapeutics that have distinct advantages in potency and efficacy over conventional drug therapy. Viron is the first company to successfully advance a viral protein drug into human testing.

Board Members and Advisors (1)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    700 Collip Circle, Suite 203

    Ontario

    London, N6G 4X8

    CAN

Images (1)

Update
  • F3afd647b1ab199822526b06bb569d77